减重手术患者中肾脏疾病与2型糖尿病缓解的关联
这项前瞻性多中心队列研究纳入737例接受减重手术的2型糖尿病患者,随访至5年,评估糖尿病缓解与肾脏疾病标志物的双向关联。结果显示糖尿病缓解与白蛋白尿风险降低相关(RR 0.66,95%CI 0.48-0.90),但与eGFR无独立关联;术前肾功能较差与糖尿病缓解可能性降低相关。
要点
- 减重术后5年糖尿病缓解与白蛋白尿中重度升高风险降低相关(RR 0.66)。
- 糖尿病缓解与eGFR无独立关联,但伴CKD预后风险稳定。
- 术前eGFR较低和CKD预后风险较高与糖尿病缓解可能性降低独立相关。
核心结论
- 减重术后5年2型糖尿病缓解与白蛋白尿改善及CKD预后风险稳定相关,但与eGFR无关。
- 减重术前肾功能较低和CKD预后风险较高与糖尿病缓解可能性降低相关。
研究设计与样本
- 前瞻性观察性研究,纳入737例接受减重手术的2型糖尿病患者,多中心队列随访长达5年。
主要发现
- 5年糖尿病缓解与白蛋白尿中重度升高风险降低独立相关(风险比0.66;95%CI 0.48-0.90),并与CKD预后风险稳定相关。
- 上述关联受基线胃饥饿素水平修饰。
- 术前eGFR较低和CKD预后风险较高与糖尿病缓解可能性降低独立相关,术前eGFR的关联受C肽水平修饰。
- 基线循环胃饥饿素较高与CKD预后风险较低独立相关。
临床怎么用
- 减重术后实现糖尿病缓解可能有助于改善白蛋白尿和稳定CKD预后风险,但需关注术前肾功能对糖尿病缓解可能性的影响。
局限性
- 少数参与者有基线CKD;缺乏对照组;无糖尿病病程、其他临床终点或肾活检信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: The association between bariatric surgery, type 2 diabetes, and chronic kidney disease (CKD) is poorly understood. We studied whether remission of type 2 diabetes induced by bariatric surgery influences markers of kidney disease, if CKD is associated with remission of diabetes after bariatric surgery, and if baseline levels of gut hormones and peptides modify these associations. STUDY DESIGN: Prospective observational study. STUDY PARTICIPANTS: 737 bariatric surgery patients with type 2 diabetes who participated in a multicenter cohort study for up to 5 years. PREDICTORS: Demographics, blood pressure, medications, type of bariatric surgery, anthropometrics, markers of kidney disease, and circulating levels of gut hormones and peptides. OUTCOMES: Estimated glomerular filtration rate (eGFR), urinary albumin excretion, prognostic risk for CKD, and remission of diabetes. ANALYTICAL APPROACH: Linear mixed models for eGFR; generalized linear mixed models with logit link for albuminuria, prognostic risk for CKD, and diabetes remission. RESULTS: Remission of diabetes at 5 years post-bariatric surgery was not independently associated with eGFR but was associated with lower risk for moderate/severe increase in albuminuria (risk ratio, 0.66; 95% CI, 0.48-0.90) and stabilization in prognostic risk for CKD. These findings were modified by baseline ghrelin level. Lower preoperative eGFR and greater prognostic risk for CKD were independently associated with reduced likelihood of diabetes remission. The association with preoperative GFR was modified by C-peptide level. Higher baseline circulating ghrelin level was independently associated with a lower prognostic risk for CKD. LIMITATIONS: A minority of participants had baseline CKD; lack of comparison group; no information on duration of diabetes, other clinical end points, or kidney biopsy results. CONCLUSIONS: Remission of type 2 diabetes 5 years after bariatric surgery was associated with improvements in albuminuria and stabilized prognostic risk for CKD, but not with eGFR. Lower kidney function and greater prognostic risk at the time of bariatric surgery was linked to a lower likelihood of diabetes remission. These results highlight the need to identify the mechanisms through which bariatric surgery may delay the long-term progression of CKD in type 2 diabetes.
引用
- Friedman AN, Wang J, Wahed AS, et al. The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes. Am J Kidney Dis. 2019. PMID: 31331758. doi:10.1053/j.ajkd.2019.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。